AN2 Therapeutics Inc

Research AN2 Therapeutics Inc (ANTX) on Bullrun: market cap USD 181.16M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerANTX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 181.16M
• Financial periodFY2025
• Net income-USD 35.17M

Valuation Snapshot

latest market cap is USD 181.16M.

About AN2 Therapeutics Inc

AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics. The company's initial candidate includes epetraborole, which is phase 3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease, as well as studying for the treatment of acute melioidosis.

Frequently asked questions

What is AN2 Therapeutics Inc's market cap?

AN2 Therapeutics Inc's market capitalization is USD 181.16M.

What does AN2 Therapeutics Inc do?

AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.